2021
DOI: 10.21203/rs.3.rs-228016/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Model Difference in the Effect of Cilostazol on the Development of Experimental Pulmonary Hypertension in Rats

Abstract: Background: Preventing pulmonary vascular remodeling is a key strategy for pulmonary hypertension (PH). Causes of PH include pulmonary vasoconstriction and inflammation. This study aimed to determine whether cilostazol (CLZ), a phosphodiesterase-3 inhibitor, prevents monocrotaline (MCT)- and chronic hypoxia (CH)-induced PH development in rats.Methods: Fifty-one male Sprague-Dawley rats were fed rat chow with (0.3% CLZ) or without CLZ for 21 days after a single injection of MCT (60 mg/kg) or saline. Forty-eight… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 62 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?